Latest News and Press Releases

Today, Ambu issues the Annual Report for the financial year 2021/22, including Sustainability Report and Remuneration Report. The reports can be found at Ambu.com. Attachments ...

Ambu delivered 4% organic revenue growth for the year 2021/22. Global Endoscopy Solutions (previously named Visualisation) revenues grew organically by 1%, mainly driven by strong growth in the ENT...

This financial calendar lists the expected dates of publication of financial announcements and the Annual General Meeting for the financial year 2022/23.  Please see attached PDF. CONTACTS ...

Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu...

Ambu delivered 8% organic revenue growth in Q3 with 5% organic growth year-to-date. This was driven by a continued rapid uptake of Ambu’s single-use endoscopes within urology and ENT, as well as...

Preliminary Q3 organic revenue growth was 8%. Visualization organic growth was 0%, Anaesthesia organic growth was 14%, and Patient Monitoring & Diagnostics (PMD) organic growth was 20%.Current...

The Board of Directors of Ambu A/S has appointed Britt Meelby Jensen as new Chief Executive Officer (CEO). Britt Meelby Jensen has served as board member of Ambu since 2019, a position she will step...

For Q2, Ambu posted organic revenue growth of 8% with reported growth of 12%. The macroeconomic headwinds with inflation and continued congestion of the global supply chain are further increasing our...

Ambu A/S hereby announces in reference to Section 30 of the Danish Capital Markets Act that on April 26, 2022, pursuant to Section 38(1) of the Danish Capital Markets Act, Ambu has received a major...

Thomas Schmidt will join Ambu as Chief Financial Officer effective 1 June and successor to Michael Højgaard who will step down after a decade in the role. The Board of Directors of Ambu A/S has...